Efficacy and safety of FABT versus FCA regimens in allogeneic hematopoietic stem cell transplantation for aplastic anemia patients

Abstract Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the primary curative treatment for Aplastic anemia (AA), especially for severe aplastic anemia (SAA). The Baltimore regimen and Fludarabine plus Cyclophosphamide/Antithymocyte globulin (FCA) regimen are commonly us...

Full description

Bibliographic Details

Main Authors:	Zhengwei Tan, Jinyu Hu, Ningning Zhu, Yuechao Zhao, Huijin Hu, Qinghong Yu, Yu Zhang, Tonglin Hu, Dijiong Wu, Baodong Ye, Wenbin Liu
Format:	Artigo
Language:	Inglês
Published:	BMC 2026-04-01
Series:	European Journal of Medical Research
Subjects:	Aplastic anemia Allogeneic hematopoietic stem cell transplantation Antithymocyte globulin Post-transplant cyclophosphamide Thiotepa
Online Access:	https://doi.org/10.1186/s40001-026-04324-w
Tags:	Add Tag No Tags, Be the first to tag this record!